Is STAAR Surgical Company overvalued?

STAAR Surgical Company (STAA) looks overvalued — trading about 39% above its fair value.

Overvalued

Price

$26.18

Fair value

$15.94

Current P/E

45.9

Normal P/E

28.0

Market cap

$1.30B

Dividend yield

0.0%

Return on equity

-6.1%

Sector

Healthcare

Fair value compares STAA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks